Clinical Trial Update: Respiratory Events Among Premature Infants

View source ↗

Summary

A completed MedImmune-sponsored clinical trial evaluated respiratory events in premature infants at risk for Respiratory Syncytial Virus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus

Drugs mentioned

• Synagis (palivizumab)

Snippet

Sponsor: MedImmune LLC | Conditions: Respiratory Syncytial Virus | Status: COMPLETED